Clinical Trials Logo

Clinical Trial Summary

To find superiority relationship between oral and intravenous administration of tranexamic acid on peroperative and postoperative blood loss, haemarthrosis prevalence and improvement functional prognosis in anterior cruciate ligament arthroscopy.


Clinical Trial Description

Tranexamic acid is an anti-fibrinolytic drug, recommended in total hip arthroplasty to reduce peroperative and postoperative hemorrhagic complications. The original character of our study lies in the serum dosage of tranexamic acid, allowing to correlate the primary objective (blood loss) with this one. The investigators will focus on the reduction of the risks associated with the administration of intravenous medicines, the economic aspect and the ease of use. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04855877
Study type Interventional
Source University of Liege
Contact Nicolas Piette, MD
Phone 003242843824
Email piettenicolas@me.com
Status Recruiting
Phase Phase 4
Start date July 6, 2021
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05487768 - Functional Connectivity After Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT04390035 - BFRT in Adolescents After ACL Reconstruction N/A
Recruiting NCT02740452 - Anterior Cruciate Ligament Rupture N/A
Not yet recruiting NCT02555917 - Comparison of Remnant Preserving Versus Remnant Resecting Anterior Cruciate Ligament Reconstruction N/A
Active, not recruiting NCT00529958 - Comparison of Three Methods for Anterior Cruciate Ligament Reconstruction N/A
Completed NCT05109871 - Reliability and Validity of Inline Dynamometry Study for Measuring Knee Extensor Torque N/A
Not yet recruiting NCT06048874 - FNB in ACL Recon Under SA N/A
Not yet recruiting NCT06048848 - FNB in ACL Recon Under GA N/A
Terminated NCT03529552 - Evaluation After Reconstruction of the Anterior Cruciate Ligament of the Knee Using the Bioresorbable Interference Screw (SMS): Resorbability, Per- and Post-operative Complications and Articular Functional Recovery. N/A
Completed NCT04285853 - Are Opioids Needed After ACL Reconstruction Phase 4
Recruiting NCT04088227 - Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears Phase 2
Active, not recruiting NCT03671421 - Number One Overall Graft Pick? Hamstring vs Bone-Patellar-Tendon-Bone vs Quadriceps Tendon N/A
Not yet recruiting NCT04953676 - A Clinical Trial of the Round-tunnel and Flat-tunnel Technique of ACL Reconstruction N/A
Not yet recruiting NCT04957706 - Diagnostic Study of ACL Rupture With Anterior Drawer Test at 90° of Hip Flexion
Enrolling by invitation NCT03365908 - Pain Management of ACL Reconstruction N/A
Recruiting NCT06030791 - BTB Graft Harvest and Donor Site Morbidity After ACL Reconstruction
Recruiting NCT03950024 - Improvement of Knowledge About the Arthrogenic Muscle Inhibition in the Aftermath of Knee Trauma. N/A
Recruiting NCT03229369 - Association of ALL and ACL Reconstruction Versus Isolated ACL Reconstruction in High-risk Population: a RCT. N/A
Completed NCT01267435 - Evaluation of Tibial and Femoral Tunnel Position After Arthroscopic Reconstruction of the Anterior Cruciate Ligament Phase 2
Recruiting NCT06430775 - Exploring Prolonged AMR in ACL Reconstructed Patients